KSH01-TCRT Solid Tumors

NCT05539833 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

TCR-T Cells
Refractory Solid Tumors
Relapsed Solid Tumors

Interventions

DRUG: KSH01 injection

Sponsor

TCRx Therapeutics Co.Ltd